Targeting gut‐derived NETosis : A paradigm shift in understanding metformin's therapeutic action

Documenti analoghi

• Similarities and differences in the intestinal actions of metformin and imeglimin
  di: Kenji Sugawara, et al.
  Pubblicazione: (2025)
• Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal Tolerability
  di: Gian Paolo Fadini, et al.
  Pubblicazione: (2026)
• The importance of treatment sequencing with SGLT2 inhibitors and GLP ‐1 receptor agonists combination for kidney function preservation in type 2 diabetes
  di: Mario Luca Morieri, et al.
  Pubblicazione: (2026)
• IDegLira for the real‐world treatment of type 2 diabetes in Italy. Final results from the REX observational study
  di: Gian Paolo Fadini, et al.
  Pubblicazione: (2024)
• ACAD10 is not required for metformin's metabolic actions or for maintenance of whole‐body metabolism in C57BL / 6J mice
  di: Michael J. Yew, et al.
  Pubblicazione: (2024)